Clinical Trial Update: Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the addition of dAroLutamide to androgen deprivation therapy and radiotherapy for newly diagnosed prostate cancer with pelvi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING